Focus Diagnostics Zika EUA Amended

Oct 13, 2016

NEW YORK (GenomeWeb) – The US Food and Drug Administration has amended the Emergency Use Authorization it issued to Focus Diagnostics for its RT-PCR Zika assay, the agency announced last week.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Menu

Focus Diagnostics Zika EUA Amended

To read the full story....

Breaking News

FDA Approves Qiagen's PIK3CA Test as Companion Test for Novartis Breast Cancer Drug

Local Coverage Determinations Roundup: Natera, Guardant Health, Transplant Genomics, and More

In Brief This Week: Invivoscribe, Todos Medical, Personalis, and More

FDA Approves CD Diagnostics' Test for Prosthetic Joint Infections

FDA Clears InBios International Zika Antibody Test

Beckman Coulter Life Sciences Recalls Hematology Analyzers Due to Risk of Inaccurate Results

Clinical Genomics of NTRK Fusion Detection in Cancer

What's Popular?

Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs

FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing

Roche Obtains FDA Clearance for Sexually Transmitted Disease Test

Qiagen Syndromic Testing System, Respiratory Panel Garner FDA Clearance

Genetic Technologies Offers $1.2M in American Depository Shares

Sponsorships